Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Tables)

v3.22.1
Acquisitions (Tables)
 3 Months Ended
Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Preliminary Allocation of Total Consideration of Assets Acquired and Liabilities Assumed
The table below summarizes the preliminary estimates of fair value of identifiable assets acquired and liabilities assumed in the Acquisition. These preliminary estimates of the fair value are subject to revisions, which may result in an adjustment to the preliminary values presented below.
(in thousands) October 22, 2021
Cash and cash equivalents $ 1,533 
Accounts receivable, net of allowance for credit losses 5,358 
Inventories, net 1,561 
Prepaid expenses and other current assets 454 
Property, plant and equipment, net 15,697 
Right of use asset, operating leases, net 208 
Intangible assets, net 5,750 
Total identifiable assets acquired 30,561 
Accounts payable 1,751 
Accrued expenses and other current liabilities 1,622 
Current portion of operating lease liabilities 51 
Current portion of finance lease liabilities 215 
Deferred income taxes 2,542 
Long-term portion of operating lease liabilities 157 
Long-term portion of finance lease liabilities 1,408 
Total identifiable liabilities assumed 7,746 
Net identifiable assets acquired 22,815 
Transaction price 34,097 
Goodwill $ 11,282 
Schedule of Business Acquisitions, by Acquisition
Total net sales and operating income for DanChem for the three months ended March 31, 2022 were as follows:
(in thousands) Three Months Ended
March 31, 2022
Net sales $ 7,474 
Operating income $ 235